Research, News & Discoveries

Second only to lung cancer, colorectal cancer is the nation’s leading cancer killer — accounting for more than 52,000 deaths in the United States each year. Colorectal cancers are divided into two main groups, based on microsatellites, or repeat sections, in their DNA. Read More

In a collaborative effort co-led by teams from Vanderbilt University Medical Center (VUMC) and the University of Michigan, a comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. The study, published Dec. 4 in… Read More

A potential schizophrenia treatment discovered through the Warren Center for Neuroscience Drug Discovery has been cleared by the U.S. Food and Drug Administration for use in phase 1 clinical trials—the third WCNDD therapeutic to reach that benchmark.  “Vanderbilt is proud that a discovery by our researchers at the Warren Center… Read More

Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Their discovery, reported Nov. 14 in the journal Nature Communications,… Read More

John McLean, Stevenson Professor of Chemistry and Chair of the Department of Chemistry, Associate Provost for Graduate Education, Director of the Center for Innovative Technologies and VICB member, has been named the winner of the 2023 EAS Award for Outstanding Achievements in Mass Spectrometry. Read More

As director of the NCI, Rathmell will lead the National Cancer Program and the NIH’s efforts to dramatically reduce the prevalence of cancer and improve the lives of cancer patients and their families through research into prevention and cancer biology, the development of new interventions, and the training and mentoring of new researchers. The NCI is the largest funder of cancer research in the world, with a fiscal year budget of $7.3 billion and comprised of approximately 3,500 employees. Read More

Two have secondary Basic Science faculty and two are VICB members are among international researchers whose publications rank in the top 1% by citations according to the global analytics firm Clarivate. Read More

“Looking back, the trip did exactly what I hoped it would: It exposed me to the vast array of career paths available to graduate students like me, from R&D and business management to investing and consulting. The connections I made with my peers, various speakers, and Vanderbilt alums are invaluable as I think about  what’s my next step,” said Amy Tran. Read More

A team of Vanderbilt researchers discovered that C. diff produces the spheres, called ferrosomes, and that these structures are important for infection in an animal model. The findings are a rare demonstration of a membrane-bound structure inside a pathogenic bacterium. Read More

Alvin C. Powers, MD, Joe C. Davis Professor of Biomedical Science and professor of Medicine, Molecular Physiology and Biophysics, has received the 2023 William S. Middleton Award, the highest honor awarded by the Department of Veterans Affairs (VA) Biomedical Laboratory Research and Development Service. Read More